Pajunen, Lotta http://orcid.org/0000-0001-5090-0662
Korkalo, Liisa http://orcid.org/0000-0002-0525-9877
Koivuniemi, Ella http://orcid.org/0000-0002-5751-3064
Houttu, Noora http://orcid.org/0000-0002-1350-2187
Pellonperä, Outi http://orcid.org/0000-0001-9272-2278
Mokkala, Kati http://orcid.org/0000-0002-0354-5546
Shivappa, Nitin http://orcid.org/0000-0003-0441-8896
Hébert, James R. http://orcid.org/0000-0002-0677-2672
Vahlberg, Tero http://orcid.org/0000-0002-4935-3056
Tertti, Kristiina http://orcid.org/0000-0001-8950-3103
Laitinen, Kirsi http://orcid.org/0000-0001-5245-8118
Funding for this research was provided by:
Academy of Finland (258606)
State research funding for university-level health research of the Turku University Hospital Expert Responsibility Area
Diabetes Research Foundation
Juho Vainion Säätiö
University of Turku (UTU) including Turku University Central Hospital
Article History
Received: 1 July 2021
Accepted: 16 November 2021
First Online: 30 November 2021
Declarations
:
: Authors declare no conflict of interest. However, see the disclosure, below.
: Dr. James R. Hébert owns a controlling interest in Connecting Health Innovations LLC (CHI), a company that has licensed the right to his invention of the dietary inflammatory index (DII<sup>®</sup>) from the University of South Carolina to develop computer and smart phone applications for patient counseling and dietary intervention in clinical settings. Dr. Nitin Shivappa is an employee of CHI. The subject matter of this paper will not have any direct bearing on that work, nor has that activity exerted any influence on this project.
: The study was conducted according to the Declaration of Helsinki and the Ethics Committee of the Hospital District of Southwest Finland (115/180/2012) approved all the procedures including human subjects.
: Written informed consent was obtained from all subjects participated in the study.
: Written informed consent included publishing their data.